European Journal of Clinical Pharmacology

, Volume 21, Issue 6, pp 505–509 | Cite as

Mezlocillin dose dependent elimination kinetics in renal impairment

  • G. R. Aronoff
  • R. S. Sloan
  • R. A. Stanish
  • N. S. Fineberg
Originals

Summary

The effect of drug dose on mezlocillin elimination kinetics was examined in six subjects with normal renal function and in six anuric patients. Each subject received mezlocillin 1, 3 and 5 g as single intravenous doses separated by one week. Elimination was not prolonged by increasing the dose in subjects with normal renal function, but elimination kinetics were dose dependent in anuric patients. Therapeutic guidelines are suggested.

Key words

renal impairment mezlocillin dose dependent elimination dosimetry 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Bodey GP, Pan T (1977) Mezlocillin: In vitro studies of a new broad spectrum penicillin. Antimicrob Agents Chemother 11: 74–79Google Scholar
  2. 2.
    Fu KP, Neu HC (1978) Azlocillin and mezlocillin: new ureido penicillins. Antimicrob Agents Chemother 13: 930–938Google Scholar
  3. 3.
    Werner H, Krasemann C, Ungerechts J, Schmitz HJ (1977) Die in vitro-Aktivität von Mezlocillin, Aslocillin, and Carbenicillin gegen Bacteroidacae unter besonderer Berücksichtigung der Fragilis-Gruppe. Infection 5: 17–21Google Scholar
  4. 4.
    Aronoff GR, Sloan RS, Luft FC, Nelson RL, Maxwell DR, Kleit SA (1980) Mezlocillin pharmacokinetics in renal impairment. Clin Pharmacol Ther 28: 523–528Google Scholar
  5. 5.
    Bergan T (1978) Pharmacokinetics of mezlocillin in healthy volunteers. Antimicrob Agent Chemother 14: 801–806Google Scholar
  6. 6.
    Bergan T, Bradwell EK, Wiik-Larsen E (1979) Mezlocillin pharmacokinetics in patients with normal and impaired renal functions. Antimicrob Agents Chemother 16: 651–654Google Scholar
  7. 7.
    Brier GL, Wolny J, Smith JW (1975) Serum bioassay for antimicrobial agents. In: Technical improvement serivce, No. 21. American Society of Clinical Pathologists, ChicagoGoogle Scholar
  8. 8.
    Pancoast SJ, Neu HC (1978) Kinetics of mezlocillin and carbenicillin. Clin Pharmacol Ther 24: 108–116Google Scholar
  9. 9.
    Gundert-Remy U, Forster D, Schacht P (1979) Pharmacokinetische Untersuchungen von Mezlocillin unter besonderer Berücksichtigung der Galleausscheidung. In: Spitzy KH, Weuta H, Weicheit E (eds) Berichte über das Internationale Symposium Acylureido-Penicilline, Stuttgart. Verlag für angewandte Wissenschaften, München, pp 137–143Google Scholar

Copyright information

© Springer-Verlag 1982

Authors and Affiliations

  • G. R. Aronoff
    • 1
  • R. S. Sloan
    • 1
  • R. A. Stanish
    • 1
  • N. S. Fineberg
    • 1
  1. 1.Indiana University and Veterans Administration Medical CenterIndianapolisUSA

Personalised recommendations